The controversy about Plan B began when HHS Secretary, Kathleen Sebelius, invoked her authority over the FDA, who had approved the drug for purchase from a pharmacy without a prescription. Ms. Sebelius, in an unprecedented move, stated that prescription dispensing requirements should not be removed for women of all ages. She believed younger teens should not have access to the pill without a prescription. Many lawmakers were surprised by this reaction and criticized the Obama administration of placing politics ahead of science.
Margaret Hamburg, FDA commissioner said "There is adequate and reasonable, well-supported, and science-based evidence that Plan B One-Step is safe and effective and should be approved for nonprescription use for all females of child-bearing potential".